Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,647 | 25,802 | 28,677 | 15,364 | 90,541 |
| Marketable Securities | 17,984 | 33,481 | 51,732 | 69,488 | 67,039 |
| Receivables | 89,587 | 78,881 | 60,137 | 52,049 | 35,499 |
| Inventories | 92,746 | 53,160 | 42,110 | 54,573 | 48,382 |
| TOTAL | $238,066 | $209,014 | $188,774 | $205,435 | $254,423 |
| Non-Current Assets | |||||
| PPE Net | 12,403 | 14,863 | 20,166 | 22,160 | 23,734 |
| Other Non-Current Assets | 5,408 | 9,270 | 13,566 | 23,356 | 27,549 |
| TOTAL | $17,811 | $24,133 | $33,732 | $45,516 | $51,283 |
| Total Assets | $255,877 | $233,147 | $222,506 | $250,951 | $305,706 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,994 | 11,709 | 3,240 | 3,225 | 3,803 |
| Accrued Expenses | 35,867 | 34,956 | 31,515 | 37,884 | 38,979 |
| TOTAL | $96,098 | $91,457 | $79,685 | $82,355 | $71,058 |
| Non-Current Liabilities | |||||
| Long Term Debt | 107,899 | 25,026 | 24,263 | N/A | N/A |
| Other Non-Current Liabilities | 37,547 | 150,315 | 152,531 | 155,024 | 157,078 |
| TOTAL | $145,446 | $175,341 | $176,794 | $155,024 | $157,078 |
| Total Liabilities | $241,544 | $266,798 | $256,479 | $237,379 | $228,136 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 188,537 | 152,330 | 150,329 | 119,259 | 102,141 |
| Common Shares | 1,883 | 1,521 | 1,503 | 1,191 | 1,020 |
| Retained earnings | -1,939,789 | -1,919,594 | -1,906,014 | -1,795,455 | -1,613,431 |
| Other shareholders' equity | 4 | 13 | 13 | -19 | -6 |
| TOTAL | $14,333 | $-33,651 | $-33,973 | $13,572 | $77,570 |
| Total Liabilities And Equity | $255,877 | $233,147 | $222,506 | $250,951 | $305,706 |